Several minimally invasive injectable modalities are safe and effective for the management of hair loss in adults with androgenetic alopecia.

On Saturday, families came together for the second annual Walk for Alopecia in Golden Gate Park. Max Darrow reports. (9-28-24 ...

Most patients with alopecia areata who had hair regrowth with baricitinib and discontinued maintenance therapy experienced a relapse of hair loss.

Hudson Therapeutics, a leading innovator in therapeutic solutions and a US subsidiary of Shaperon, announced Shaperon’s entry ...

Kristen Whitney, DO, FAAD, determines systemic treatment options for severe alopecia areata based on the patient’s medical history, past treatments tried, potential adverse events, in addition ...

Arash Mostaghimi, MD, MPA, MPH, assistant professor of dermatology, director of the inpatient dermatology consult service, and codirector of the Complex Medical Dermatology Fellowship at Brigham & ...

Medically reviewed by Brian T. Luong, DMDMedically reviewed by Brian T. Luong, DMD Tooth agenesis is a genetic condition ...

It can come in a variety of forms, including one of the most commonly known as alopecia areata. Famous women who live with alopecia include Jada Pinkett Smith and “Summer House: Martha’s ...

Alopecia areata is an autoimmune disease, where the body's immune system attacks the follicles of the hair, causing it to fall out. Alopecia is more than just hair loss Toby Penty on alopecia ...

Researchers at the University Hospital Bonn and the University of Bonn have now identified causative mutations in another keratin gene ... (IMSDs), such as alopecia areata, atopic dermatitis ...

Metformin significantly improved symptoms and resulted in hair regrowth in Black women with treatment-refractory central centrifugal cicatricial alopecia ... to evaluate gene expression changes.

A lot of people have a short experience of hair loss and it will come back, they might not have Alopecia Areata, which I originally had, before it developed into Alopecia Universalis, meaning I ...